Global hormone replacement
therapy market is expected to reach USD 28.4 billion by 2022, according to a
new report by Grand View Research, Inc. Increasing geriatric and neonatal
population base, growing cases of hormonal imbalances, and large presence of unmet
healthcare needs in emerging economies are some vital impact rendering drivers.
Estrogen replacement therapy
dominated the market in 2015. Moreover, the rising number of women reaching the
menopausal age is expected to drive the demand for these treatments over the
forecast period.
Furthermore, rise in premature
births that lead to genital disorders and slower rate of growth in these
neonates are anticipated to fuel the demand for growth hormone therapy.
According to statistics provided by the CDC, over 15 million babies were born
preterm in 2014 annually. This number is anticipated to rise over the next
seven years and become a leading cause for disabilities, illnesses, arrested
development, and mortality.
In depth research report on Hormone Replacement Therapy
(HRT) Market
Further key findings from the study suggest:
·
Estrogen therapy is expected to
dominate the product segment and hold over 50.0% of the market share by 2022.
This growth can be attributed to the increasing focus of healthcare bodies such
as the Women’s Health Initiative, The North America Menopause Society, and The
British Menopause Society, on providing safe replacement therapy.
·
The parenteral route of
administration is commonly used for delivery of drugs such as Nutropin,
Signifor, Genotropin, and Tev-Tropin. Other routes such as pen-based delivery
systems and implants are gaining popularity owing to higher patient comfort and
ease-of-use. Furthermore, technological advancements in the field providing
higher bioavailability of drug and needle-free administration are predicted to
positively impact growth.
·
Menopause and their vasomotor
symptoms are expected to be the most prevalent disease over the forecast period
owing to increasing number of women approaching the menopausal age. The segment
is predicted to hold about 40.0% of the market share by 2022.
·
North America, particularly the
U.S. dominated the market and held about 35.0% of the total revenue in 2015.
Existence of well-regulated healthcare system and presence of a large pool of
target population are a few factors that promote growth. Countries such as
South Africa, China, India, and Brazil are anticipated to witness lucrative
growth over the forecast period, with China predicted to have the fastest
growth of over 10.0%.
·
Some key companies catering to
hormone replacement therapies include Pfizer, Inc., Merck Serono, Novo Nordisk,
Eli Lilly, Bayer Healthcare, Mylan Laboratories, Amgen, Novartis, and
Genentech. Introduction of new formulations and development of innovative drug
delivery systems are expected to be a few initiatives taken by these players
over the forecast period.
Grand View Research has
segmented the hormone replacement therapy market on the basis of product, route
of administration, disease type, and region
Hormone Replacement Therapy Market Product Outlook
(Revenue, USD Million, 2012 - 2022)
·
Estrogen Replacement Therapy
·
Human Growth Hormone
Replacement Therapy
·
Thyroid Replacement Therapy
·
Other
Hormone Replacement Therapy Market Route Of Administration
Outlook (Revenue, USD Million, 2012 - 2022)
·
Oral
·
Parenteral
·
Transdermal
·
Other
Hormone Replacement Therapy Market Type Of Disease Outlook
(Revenue, USD Million, 2012 - 2022)
·
Menopause
·
Hypothyroidism
·
Male Hypogonadism
·
Growth Hormone Deficiency
·
Other
Hormone Replacement Therapy Market Regional Outlook
(Revenue, USD Million, 2012 - 2022)
·
North America
·
U.S.
·
Canada
·
Europe
·
UK
·
Germany
·
Asia Pacific
·
Japan
·
China
·
Latin America
·
Brazil
·
Mexico
·
MEA
·
South Africa
·
Saudi Arabia
Browse more research reports of this category:
About Grand View Research
Grand View Research, Inc. is a
U.S. based market research and consulting company, registered in the State of
California and headquartered in San Francisco. The company provides syndicated
research reports, customized research reports, and consulting services. To help
clients make informed business decisions, the company offers market
intelligence studies ensuring relevant and fact-based research across a range
of industries including technology, chemicals, materials, healthcare and
energy.
For more market analysis reports, please visit: http://www.grandviewresearch.com/
No comments:
Post a Comment